AMISULPRIDE
| Brand name | BARHEMSYS |
|---|---|
| Active ingredient | AMISULPRIDE |
| Strength | 5MG/2ML (2.5MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | February 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11357753 | February 2038 | use U-2754 |
| 12329740 | February 2038 | use U-3467 |
| 12005042 | February 2038 | use U-2754 |
| 9084765 | February 2034 | use U-3467 |
| 10525033 | March 2031 | product |
| 9889118 | March 2031 | use U-1744 |
| 12194022 | March 2031 | use U-3467 |
| 9545426 | March 2031 | use U-2754 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.